Member Info for Elartu

Well done Davy. Ain't no stopping you now.

Hi tb1416, I'm LR2 from over on advfn. I use elartu over here because lse required a 4 character minimum name when I joined and I chose 'elartu' as it was phonetically the same as LR2. I generally post over on advfn because someone who posted on this site tried to get me banned here many moons ago and I took umbrage at this site removing a number of my posts on just his say so. I do read all that is posted here but tend only to post if I find interesting info or to try and answer other posters questions.

The initials of the guy who tried to get me banned happen to be TB just like your board name. I am cautious when I see those initials. Luckily you are an engineer whereas he runs a few AIM companies and has a number of disgruntled shareholders. I'm certain I will find you far more trustworthy than him.

Good luck with your investment here. You will need patience as the company need to sign up and reveal 4-5 more hospital trusts to make a significant breakthrough. However, once they do the share price should be much higher than the current range.

In passing, you should note that Bleepa sales to the veterinary world and armed forces medics are under consideration. Sales to either of those areas could also kick up the price range.

Follow the link on the tweet below.

https://twitter.com/FBKmed/status/1381884157224226818

It was delayed but turned up eventually. Well done.

30-Mar-21 12:43:14 1.3089p 1,000,000

Looks like £291 mil is just procurement fraud. At the bottom of the following link it says, "We estimate that the NHS is vulnerable to £1.21 billion worth of fraud each year." Now that is staggering if true.

https://cfa.nhs.uk/reportfraud

Ian, there is a presentation coming up.

Investor Presentation

The Company is pleased to announce that Tom Oakley, CEO of Feedback, will provide a live presentation relating to today's announcement via the Investor Meet Company platform on Tuesday 30 March 2021 at 12:00pm BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9.00am BST the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Feedback plc via:

https://www.investormeetcompany.com/feedback-plc/register-investor

Investors who already follow the Company on the Investor Meet Company platform will be automatically invited.

Congratulations to Investor Bill for giving everyone here the heads up on this news 14 days ago.

https://twitter.com/DrTomOakley/status/1369265893973364739

Hi Calculus, the Royal Berkshire Trust is new to me. I posted on the other place just before popping out for a hospital appointment myself this morning. I see IB beat me to the information this morning so congratulations must go to him for this find. I consider it to be very important and am having a spiced rum and coke to celebrate.

Thank you Calculus. I'm just here to open his eyes and help him to see clearly.

https://www.youtube.com/watch?v=MrHxhQPOO2c

"Firstly they will arrange the next raise before the cash has been spent." - Of course they will. Everyone does. Your original post however doesn't postulate any sales whatsoever in the intervening period so your timeframe is skewed to a negative outcome.

"They are spending, going to India, tweaking the product, giving it away for free, setting up support workers to help the free users .." - not so, the Indian trade mission was a virtual initiative (no travel involved), the product tweaks have been completed and the product is now in the market place, the give away ended with PAHT (they were the product testing centre), the support workers are in place for future sales not to aid in more free use.

"I think you are in for a surprise ?" - I believe you are in for a surprise.

The company had a positive cash balance of £4.4mln as at the end of September 2020.
https://www.investegate.co.uk/feedback-plc--fdbk-/rns/agm-statement/202011050700022989E/

And this had dropped to a positive cash balance of £3.78mln as at the end of November 2020.
https://www.investegate.co.uk/feedback-plc--fdbk-/rns/half-year-report/202102230700039572P/

So, expenditure of £620k in 2 months.
Thus a fairly current expenditure of £310k per month.

However, latest accounts show £672k was spent on software development in the 6 months to Nov '20.
That software development expenditure has now stopped and Bleepa is in the market place.

Saving on completed software development spread over all 6 months equals £112k a month though I expect the software development did not take place over the full 6 months.

Monthly expenditure of £310k per month minus completed software (and therefore no longer on-going) cost of £112k a month would mean current monthly expenditure in the region of £198k per month.

Cash at end Nov '20 of £3.78 mil / £198k a month on-going expenditure would indicate company will remain solvent for 19 months.
However new staff have been recruited so it would be reasonable to assume a reduction to the previous calculation of 19 months.

Assuming new staff costs are approx. £25k a month then £3.78 mil / £223k would indicate company will remain solvent for almost 17 more months.

So, I would expect any new cash call to be at least 12 months away unless Bleepa sales take off like a Japanese bullet train in the next 2-3 months, in which case raising more money earlier may be the expedient option.

It can be a good sign when buying gets hidden.

Here's the video link if anyone wants it.

https://youtu.be/-mt-qWLy4kg

Tom Oakley chats with the Leaders Council. First 8 minutes.

https://www.youtube.com/watch?v=wFFoSNeGFPc

Thanks IB. I snapped a bit yesterday as I was feeling pretty rough after an anti-Covid jab. Will probably continue posting on both sites. Nothing found today but that 1.8 million buy this morning was interesting.

HTN Video Interview: Dr Tom Oakley, Bleepa

https://htn.co.uk/2021/02/16/htn-video-interview-tom-oakley-bleepa/

Not enough selling for the buyers to appear. The buyers had the day off. They are in no hurry to raise the price here.

https://htn.co.uk/2021/01/21/htn-now-awards-2021-feature-outstanding-digital-pathways-in-the-uk/

Feedback’s Bleepa tool saves time for Pennine Acute Hospitals

Feedback’s Bleepa tool is a medical imaging-based platform that can improve patient care by enabling quick and secure remote communication between clinicians.

Said to be ‘designed by clinicians for clinicians’, it offers a state-of-the-art messaging app that means medical staff can securely view and discuss ‘high quality medical grade images’ on mobile devices.

As for a real-world example, Pennine Acute Hospitals NHS Trust reported a reduction in referral time of ‘7.4 days to under one’.

Don't think this has been posted before. Bleepa squeezed on to the list at No. 15.

https://stlpartners.com/digital-health-telecoms/digital-health-companies-2021/

Bleepa is a communications platform designed for medical staff in hospital settings. It combines secure, instant messaging with the ability to share clinical grade medical images (e.g. x-rays). This means that medical staff dispersed throughout a hospital location can review images, discuss points and come to collective decisions in an expedited manner. With any communications platform – particularly one that deals with sensitive healthcare data – there is always the question of privacy. As Bleepa is healthcare software, the hospital has responsibility for the data and its management.

Bleepa is available on the NHSx Clinical Communication Tools Framework. Amid COVID-19 and the pressure that hospitals are facing, communication tools that save time for medical staff, in turn speeding up care for patients, are critical.